title: Methotrexate in psoriasis: do we need to give a test dose?
authors.affiliation: Servicio de Dermatología, Hospital Universitario de Gran Canaria, Las Palmas de Gran Canaria, Spain. gcarrete@aedv.es
authors.forename: G
authors.initials: G
authors.lastname: Carretero-Hernández
mesh_terms: D001855:Bone Marrow Diseases / Q000139:chemically induced / Q000517:prevention & control; D004305:Dose-Response Relationship, Drug; D003875:Drug Eruptions / Q000209:etiology / Q000517:prevention & control; D004342:Drug Hypersensitivity / Q000209:etiology / Q000517:prevention & control; D005492:Folic Acid / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D008727:Methotrexate / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D011014:Pneumonia / Q000139:chemically induced / Q000517:prevention & control; D017410:Practice Guidelines as Topic; D011565:Psoriasis / Q000188:drug therapy*; D013281:Stomatitis, Aphthous / Q000139:chemically induced / Q000517:prevention & control
chemical_list: D007166:Immunosuppressive Agents; D005492:Folic Acid; D008727:Methotrexate